Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
Dylan M. Glubb(QIMR Berghofer Medical Research Institute), Jan Gawełko(University of Rzeszów), Katja K.H. Aben(Radboud University Nijmegen), Christine M. Friedenreich(University of Calgary), Deborah J. Thompson, Stefanie Burghaus, Ralf Bützow(Helsinki University Hospital), Katharina Bischof(Haukeland University Hospital), Linda S. Cook, Marcus Q. Bernardini(University Health Network), Ahmad Alsulimani(Jazan University), Peter A. Fasching(Universitätsklinikum Erlangen), Line Bjørge(Haukeland University Hospital), Ailith Ewing(Cancer Research UK), Michael E. Carney(The University of Texas MD Anderson Cancer Center), Fiona Bruinsma(Cancer Council Victoria), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Frédéric Amant(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), James M. Flanagan(QIMR Berghofer Medical Research Institute), Clara Bodelón(American Cancer Society), Andrew Berchuck(General Marble (Greece)), Alison M. Dunning(University of Cambridge), George Fountzilas(Hellenic Cooperative Oncology Group), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), Daniela Annibali(Institute of Molecular Biology and Pathology), Andreas du Bois(Kliniken Essen-Mitte), Hui Cai(Vanderbilt University Medical Center), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), John Attia(University of Newcastle Australia), Immaculata De Vivo(Brigham and Women's Hospital), Daniel D. Buchanan(The Royal Melbourne Hospital), Aurelio Barricarte(Instituto de Salud Pública de Navarra), Louise A. Brinton(National Cancer Institute), Robert P. Edwards(Cancer Research UK Technology), Bo Gao(Sun Yat-sen University), Jennifer A. Doherty(Cancer Prevention Institute of California), Alison H. Brand(The University of Sydney), Mia M. Gaudet(Cancer Prevention Institute of California), Matthias Dürst(Jena University Hospital), Stephen J. Chanock(National Cancer Institute), Zhihua Chen(Shanghai University), Chu Chen(Yunnan University of Finance And Economics), Sarah Ferguson(Princess Margaret Cancer Centre), Todd Edwards(Vanderbilt University Medical Center), Marina Bermisheva(Russian Academy of Sciences), Florentia Fostira(National Centre of Scientific Research "Demokritos"), Julie M. Cunningham(Cancer Research UK)
Cited by 25
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
|Nature Genetics|2010|3k